Srinagar, Nov. 8 -- NPPA says consumers are expected to save Rs 3,502 crore annually

NEW DELHI: Prices of more than 1,000 anti-cancer medicine formulations across different brands will come down from November 9 following the government's decision to cap trade margins on 137 anti-cancer drugs, with estimated annual savings to consumers projected at Rs 3,502.31 crore.

The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has capped trade margins at 30 per cent on the maximum retail price (MRP) of the identified medicines. The decision follows recommendations of an expert committee constituted by the Directorate General of Health Services (DGHS) under the Minis...